Registry Outcomes Support Ultrathin Sirolimus Stent Registry Outcomes Support Ultrathin Sirolimus Stent

Compared with other frequently used newer-generation drug-eluting stents, the ultra-thin sirolimus-eluting device was associated with lower target lesion revascularization rates, new registry data suggest.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
More News: Cardiology | Heart